A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.

Saved in:
Bibliographic Details
Title: A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.
Authors: Michaelson MD; Claire and John Bertucci Center for Genitourinary Cancers, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA dmichaelson1@mgh.harvard.edu., Gupta S; Masonic Cancer Center, Minneapolis, Minnesota, USA., Agarwal N; Huntsman Cancer Institute, Salt Lake City, Utah, USA., Szmulewitz R; University of Chicago, Chicago, Illinois, USA., Powles T; Barts Cancer Institute, London, UK., Pili R; Indiana University, Indianapolis, Indiana, USA., Bruce JY; University of Wisconsin, Madison, Wisconsin, USA., Vaishampayan U; Karmanos Cancer Center, Detroit, Michigan, USA., Larkin J; The Royal Marsden, London, UK., Rosbrook B; Pfizer Oncology, San Diego, California, USA., Wang E; Pfizer Oncology, San Diego, California, USA., Murphy D; Pfizer Oncology, San Diego, California, USA., Wang P; Pfizer Oncology, Shanghai, People's Republic of China., Lechuga MJ; Pfizer Oncology, Milan, Italy., Valota O; Pfizer Oncology, Milan, Italy., Shepard DR; Cleveland Clinic, Cleveland, Ohio, USA.
Source: The oncologist [Oncologist] 2019 Sep; Vol. 24 (9), pp. 1151-e817. Date of Electronic Publication: 2019 Jun 06.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1634/theoncologist.2018-0749